The 20 Best Schizophrenia Doctors near Baltimore, MD

Joshua Chiappelli is a Psychiatrist in Baltimore, Maryland. Dr. Chiappelli is rated as an Elite provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia, Schizoaffective Disorder, Bipolar Disorder (BPD), and Major Depression. Dr. Chiappelli is currently accepting new patients.

Akira Sawa is a Psychiatrist in Baltimore, Maryland. Dr. Sawa is rated as an Elite provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia, Bipolar Disorder (BPD), Autism Spectrum Disorder, Neurofibromatosis, and Deep Brain Stimulation.

Dr. Frederick Nucifora is an assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. His areas of clinical expertise include adult psychiatry. Dr. Nucifora earned his medical degree from the Philadelphia College of Osteopathic Medicine. He completed his residency at The Johns Hopkins Hospital’s Department of Psychiatry and Behavioral Science, where he also performed a fellowship in psychiatry. His research interests include the molecular and biological etiology of psychiatric illnesses, including schizophrenia and Huntington’s disease. Dr. Nucifora is rated as a Distinguished provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia, Schizoaffective Disorder, Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), and Deep Brain Stimulation.

Robert Buchanan is a Psychiatrist in Catonsville, Maryland. Dr. Buchanan is rated as an Elite provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia, Schizoaffective Disorder, Autism Spectrum Disorder, and Bipolar Disorder (BPD).

Bernadette Cullen is a Psychiatrist in Baltimore, Maryland. Dr. Cullen is rated as an Advanced provider by MediFind in the treatment of Schizophrenia. Her top areas of expertise are Schizophrenia, Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), and Major Depression.

Dr. Potash returned to Johns Hopkins as Director of Psychiatry and Psychiatrist-in-Chief in 2017. Prior to that he was Chair and Department Executive Officer of the University of Iowa Department of Psychiatry from 2011-17. Dr. Potash graduated in 1984 from Yale College, where he majored in English. Following graduation, he served in the Peace Corps in the West African country of Senegal, and there decided to become a physician. He completed his master’s degree in public health at Johns Hopkins, focusing on epidemiology and international health. He then went on to medical school at Hopkins, medical internship at Hopkins Bayview, and a year working as a general practitioner in another West African country, Benin. He returned to do his psychiatric residency at Hopkins and served as chief resident in 1997-98. He then joined Dr. Ray DePaulo’s mood disorders program, and eventually became the program’s research director before moving to Iowa. Dr. Potash’s work has focused on investigation of the genetic and epigenetic basis of mood disorders—depression and bipolar disorder. These efforts have resulted in over 170 publications and consistent NIH funding. He has been particularly interested in the genetic basis of the psychotic forms of bipolar disorder, and in the epigenetic mechanisms through which stress plays a role in depression. Dr. Potash co-leads the Bipolar Sequencing Consortium, and is a member of the Council on Research for the American Psychiatric Association. He serves as Treasurer for the International Society for Psychiatric Genetics, and he has played a leading role in the National Network of Depression Centers. In addition to his research endeavors, Dr. Potash is also an active clinician who sees mood disorders patients in the inpatient and outpatient settings. Dr. Potash is rated as an Advanced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Bipolar Disorder (BPD), Major Depression, Schizophrenia, and Autism Spectrum Disorder.

Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as an Advanced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

Dr. Allison S. Brandt is an Assistant Professor of Psychiatry in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. Dr. Brandt received her undergraduate degree from Harvard University, a Master of Philosophy (MPhil) in Development Studies from the University of Oxford, and her M.D. from Johns Hopkins. She completed her psychiatry residency at Massachusetts General Hospital and McLean Hospital, where she was chief resident. Her clinical expertise is in community mental health and the treatment of schizophrenia. Her research focus is on improving access to clozapine for people with treatment resistant schizophrenia. Dr. Brandt is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. Her top areas of expertise are Bipolar Disorder (BPD), Major Depression, Schizophrenia, and Seasonal Affective Disorder (SAD).

"O. Joseph (""Joe"") Bienvenu, M.D., Ph.D. is the Judy Yin Shih, PhD Professor in Anxiety Disorders at Johns Hopkins. He completed his psychiatric training at Johns Hopkins in 1996, having served as chief resident in his final year. Dr. Bienvenu joined the faculty full-time in 1999 after completing a research fellowship in psychiatric epidemiology and a doctorate through the Johns Hopkins Graduate Training Program in Clinical Investigation. His current area of particular research interest is psychiatric morbidity in critical illness survivors, particularly posttraumatic stress disorder and related conditions. Dr. Bienvenu directs the academic program for resident education in anxiety disorders, which includes the John and Mary McGlasson Anxiety Disorders Clinic, as well as the psychiatric Residents' Outpatient Continuity Clinic, and the inpatient Consultation-Liaison services at Johns Hopkins Hospital.". Dr. Bienvenu is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), Delirium, and Major Depression.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Dr. Sarah Andrews is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. She completed both her medical school education and Psychiatry residency training at Johns Hopkins. She served as a Chief Resident during residency. After residency, she joined the Department of Psychiatry to pursue her interests in both transplant and substance abuse research. She serves as a consultation psychiatrist within the Comprehensive Transplant Center, completing evaluations and providing on-going psychiatric care for transplant patients. She also serves as the Service Line Director for both the Intensive Treatment Unit, an acute inpatient detoxification unit, and the Motivated Behaviors Unit, a dual diagnosis unit, at Johns Hopkins. Her interests include integrating mental health treatment into the care of transplant patients, managing substance abuse in transplant patients, and improving long-term outcomes following acute detoxification. Dr. Andrews is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. Her top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Schizophrenia, Bipolar Disorder (BPD), and Vertebroplasty.

Jacob Taylor is a Psychiatrist in Baltimore, Maryland. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia and Bipolar Disorder (BPD).

Glenn Jordan Treisman is the Eugene Meyer III Professor of Psychiatry and Medicine at the Johns Hopkins University School of Medicine. He is Director of the AIDS Psychiatry Service, The Pain Treatment Program, and his most-recent effort as co-director of the Amos Center, a program that studies atypical GI disorders and the relationship between food, the nervous system of the GI tract, the microbiome, and disease. The Pain treatment Program provides care for chronic pain syndromes and is a national referral resource for patients with intractable pain. Dr. Treisman is internationally known for his engaging presentations, his efforts to promote the integration of psychiatry and medicine, and his vigorous commitment to the betterment of patient care for underserved populations. He is best known for his groundbreaking work in the field of HIV, where he has been described as “the father of AIDS psychiatry.” He is involved in the care of psychiatrically ill HIV infected patients and has been since early in the epidemic. He described and has raised awareness of the role of mental illness as a driving force in the HIV epidemic as well as a barrier to effective care. He is the author of The Psychiatry of AIDS, the first comprehensive textbook on the subject, as well as numerous articles on the issues of mental health in the HIV clinic. As part of a lifelong commitment to education, Dr. Treisman directed the residency program in Psychiatry for nine years, and has delivered lectures at the Johns Hopkins School of Medicine in courses on Neuroscience, Psychiatry, Pharmacology Clinical Skills, and the Physician in Society course, as well as lectures in the School of Public Heath, the School of Nursing, and in numerous departments. He is considered to be an outstanding teacher and has received the Chairman’s Award for Teaching from the Department of Medicine. His lectures on psychiatry and medical ethics have earned him international invitations and eponymous lectures including the prestigious Mapother Lecture in London and Findling Lecture at the Mayo Clinic. Dr. John G Bartlett has referred to his lecture on DNR orders and medical ethics as “the Gettysburg Address of medicine,” and The American College of Physicians recognized his work with the presentation of the William C. Menninger Memorial Award for Distinguished Contribution to the Science of Mental Health. Dr. Treisman is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Major Depression, Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), and Inappropriate Sinus Tachycardia (IST).

Irving Reti, MBBS is a research psychiatrist at The Johns Hopkins University. Dr Reti heralds from Sydney, Australia where he completed medical school at the University of Sydney before coming to Johns Hopkins for psychiatry residency. After completing a post-doctoral fellowship in neuroscience, he established his own laboratory which is focused on the field of brain stimulation. He is a Professor in the Departments of Psychiatry and Neuroscience and is Director of The Electroconvulsive Therapy (ECT) Service at The Johns Hopkins Hospital. He founded The Brain Stimulation Program at Johns Hopkins in 2008 which has an active preclinical and clinical research program as well as offering specialty consultation and treatment with brain stimulation treatment modalities including transcranial magnetic stimulation (TMS). Clinical research focuses on TMS and its application in diverse populations including patients with traumatic brain injury. Dr Reti also directs a laboratory investigating aspects of synaptic plasticity related to brain stimulation and motivated behavior. He is interested in learning more about how ECT works and is conducting studies implicating the immediate early gene Narp in mediating the antidepressant behavioral effects of electroconvulsive seizures in mice. His other major focus is developing alternate treatments to maintenance ECT, such as deep brain stimulation, for autistic patients he has treated with severe self-injury who remain dependent on ECT to suppress this behavior. Dr. Reti is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Major Depression, Seasonal Affective Disorder (SAD), Bipolar Disorder (BPD), Deep Brain Stimulation, and Rhizotomy.

Larry Alessi is a Psychiatrist in Baltimore, Maryland. Dr. Alessi is rated as an Advanced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Bipolar Disorder (BPD), Schizophrenia, Seasonal Affective Disorder (SAD), and Schizoaffective Disorder.

Dr. Onyike is a specialist in neuropsychiatry. He focuses on the diagnosis and care of neurodegenerative diseases that develop in midlife or earlier. These include frontotemporal dementias, young-onset Alzheimer diseases, prion diseases, leukodystrophy and other atypical conditions that cause cognitive and behavioral impairments and dementia. He is also engaged in research focused on the epidemiology and treatment of frontotemporal dementias, Alzheimer disease, Lewy body disease, spinocerebellar ataxias, and other neurodegenerative disorders. Dr. Onyike has advised national and international research agencies, and philanthropic organizations, including the NIH, FDA, MRC-UK, and others. He is chair-elect of the Medical Advisory Council of the Association for Frontotemporal Degeneration, and serves on the Scientific Advisory Boards of the FTD Disorders Registry, the Tau Consortium, and the International Society for Neurodegenerative Diseases. He serves on the Alzheimer’s Association Best Clinical Practices Guidelines Work Group, and has participated in NIA/NINDS Alzheimer’s Disease and Related Dementias workshop committees. He is a founding member of the International Society for Frontotemporal Dementias, and a member of the Executive Committee. Dr. Onyike is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Seasonal Affective Disorder (SAD), Major Depression, Bipolar Disorder (BPD), and Vascular Dementia.

Russell Margolis is a Psychiatrist in Baltimore, Maryland. Dr. Margolis is rated as a Distinguished provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Schizophrenia, Dementia, Bipolar Disorder (BPD), and Schizoaffective Disorder.

Jennifer Meuchel is a Psychiatrist in Baltimore, Maryland. Dr. Meuchel is rated as an Advanced provider by MediFind in the treatment of Schizophrenia. Her top areas of expertise are Schizophrenia, Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), and Major Depression.

Dr. Anne Ruble is Director of The Jerome Frank Program in Psychotherapy and Associate Program Director of the Johns Hopkins Department of Psychiatry and Behavioral Sciences Adult Psychiatry Training Program. She completed her undergraduate degree at Kenyon College and her medical and M.P.H. training at the Northwestern University Feinberg School of Medicine. She completed her adult psychiatry residency and the Alexander Wilson Schweizer fellowship in mood disorders at Johns Hopkins. She has a community psychiatry outpatient practice at Johns Hopkins Hospital Community Psychiatry Clinic and teaches family therapy to the PGY-3 residents utilizing emotionally focused psychotherapy and attachment. Her interests include best practices in psychotherapy supervision, video-based education for residents, patients, and families, and therapeutic alliance in psychotherapy. She is currently developing a curriculum for integration of patient background contributors and narrative to improve therapeutic alliance in supportive psychotherapy. She also teaches psychodynamic seminar to PGY-3 residents. She is the Co-Medical Director for the Broadway Center for Addiction outpatient substance use program and has an interest in psychotherapy for co-occurring disorders. Research Summary Dr. Ruble’s research efforts include evaluation of psychotherapy curricula and integration of psychotherapy into substance use outpatient practice. Dr. Ruble is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. Her top areas of expertise are Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), Major Depression, and Schizophrenia.

Daniel Ebert is a Psychiatrist in Baltimore, Maryland. Dr. Ebert is rated as an Experienced provider by MediFind in the treatment of Schizophrenia. His top areas of expertise are Bipolar Disorder (BPD), Schizoaffective Disorder, Seasonal Affective Disorder (SAD), and Major Depression.